News

Filter

Current filters:

None

Popular Filters

76 to 100 of 8797 results

New Zealand to fund Norgine’s Xifaxan for hepatic encephalopathy

New Zealand to fund Norgine’s Xifaxan for hepatic encephalopathy

15-07-2014

New Zealand Pharmaceutical Management Agency PHARMAC has awarded a tender to Netherlands-headquartered…

Antibiotics and Infectious diseasesFinancialHealthcareNew ZealandNorginePharmaceuticalXifaxan

moksha8 to commercialize BIAL’s eslicarbazepine in Brazil and Mexico

moksha8 to commercialize BIAL’s eslicarbazepine in Brazil and Mexico

15-07-2014

Portuguese drugmaker BIAL and Brazil-based moksha8 have entered an exclusive license for the commercialization…

BIALBrazileslicarbazepineExaliefLicensingMexicoMoksha8NeurologicalPharmaceuticalPortugalZebinix

Codexis leaps on licensing deal with GlaxoSmithKline

Codexis leaps on licensing deal with GlaxoSmithKline

15-07-2014

Codexis, a developer of biocatalysts for the pharmaceutical and fine chemical industries, saw its share…

CodeEvolverCodeEvolver protein engineering platform technologyCodexisGlaxoSmithKlineLicensingPharmaceuticalProductionUK

Breakthrough therapy designation likely to positively influence oncologists

Breakthrough therapy designation likely to positively influence oncologists

15-07-2014

Breakthrough therapy designation is likely to positively influence perceptions of the drug for both oncologists…

Decision Resources GroupOncologyPharmaceuticalRegulationUSA

Ariad says PRAC requires additional data on Iclusig

Ariad says PRAC requires additional data on Iclusig

15-07-2014

US specialty pharma firm Ariad Pharmaceuticals says that the Pharmacovigilance Risk Assessment Committee…

Ariad PharmaceuticalsEuropeIclusigOncologyPharmaceuticalPharmacovigilance Risk Assessment CommitteeRegulation

Boehringer Ingelheim’s Pradaxa available in UK for DVT

Boehringer Ingelheim’s Pradaxa available in UK for DVT

15-07-2014

German family-owned drug major Boehringer Ingelheim says that Pradaxa (dabigatran etexilate) will be…

Boehringer IngelheimDeep vein thrombosisHematologyPharmaceuticalPradaxaRegulationUK

FDA accepts Teva’s NDA for albuterol MDPI

FDA accepts Teva’s NDA for albuterol MDPI

15-07-2014

Israel-based generic giant Teva Pharmaceuticals Industries says that the US Food and Drug Administration…

albuterolExercise-induced bronchospasmGenericsPulmonologyRegulationRespiratory and PulmonaryTeva Pharmaceutical IndustriesUSA

US Pharma and BIO appeal Alameda Ordinance on drug disposal

US Pharma and BIO appeal Alameda Ordinance on drug disposal

15-07-2014

The counsel for the Pharmaceutical Research and Manufacturers of America (PhRMA), joined by the Biotechnology…

LegalPharmaceuticalRegulationUSA

GSK spies indicted in China for illegally obtaining information

GSK spies indicted in China for illegally obtaining information

15-07-2014

A couple allegedly working for UK pharma major GlaxoSmithKline in China have been indicted in Shanghai…

ChinaGlaxoSmithKlineGSKLegalPharmaceuticalXinhua News AgencyXinhua News Agency

Global regenerative medicine market expected to reach $67 billion by 2020

Global regenerative medicine market expected to reach $67 billion by 2020

15-07-2014

The global regenerative medicine market will reach $67.6 billion by 2020, up from $16.4 billion in 2013…

BiotechnologyGlobalImmunologicalsMarkets & MarketingRegenerative medicineResearchStem cells

Targacept trial does not show superiority of TC-1734 over donepezil

Targacept trial does not show superiority of TC-1734 over donepezil

15-07-2014

US-based clinical-stage biopharma company Targacept has announced results from a Phase IIb monotherapy…

Alzheimer's diseaseDonepezilNeurologicalPharmaceuticalResearchTargaceptTC-1734USA

Janssen files to expand label for Invega Sustenna to show delayed time to relapse in schizophrenia

Janssen files to expand label for Invega Sustenna to show delayed time to relapse in schizophrenia

15-07-2014

US health care giant Johnson & Johnson’s Europe-based subsidiary Janssen has submitted a supplemental…

Invega SustennaJanssenNeurologicalPharmaceuticalRegulationSchizophreniaUSA

Multinational and Indian drugmakers to face another price cap

Multinational and Indian drugmakers to face another price cap

15-07-2014

In a major blow to drug companies, India's National Pharmaceutical Pricing Authority (NPPA) has decided…

IndiaNational Pharmaceutical Pricing AuthorityPharmaceuticalPricing

Abbott Labs sells branded generics business to Mylan in $5.3 billion deal

Abbott Labs sells branded generics business to Mylan in $5.3 billion deal

14-07-2014

Following a weekend of rumors and speculation, USA-based generics major Mylan and health care firm Abbott…

Abbott LaboratoriesAustraliaCanadaEuropeFinancialGenericsJapanMergers & AcquisitionsMylanNew Zealand

Hemispherx links with SA biotech Bioclones on cancer vaccine

Hemispherx links with SA biotech Bioclones on cancer vaccine

14-07-2014

USA-based Hemispherx Biopharma has entered a strategic alliance to develop multiple projects with Bioclones,…

AlferonAmpligenBioclonesBiotechnologyHemispherx BioPharmaOncologyResearchSouth AfricaVaccines

Medac’s Rasuvo approved for RA while Antares’ injunction is denied

Medac’s Rasuvo approved for RA while Antares’ injunction is denied

14-07-2014

USA-based Medac Pharma, a wholly-owned subsidiary of privately-held German firm medac GmbH, says that…

Antares PharmaAnti-Arthritics/RheumaticsLegalMedac PharmaPharmaceuticalRasuvoRegulationUSA

76 to 100 of 8797 results

Back to top